RxDoctor Payments Data
★ My doctorsLook up a doctor →

Helen Perakis, MD

Plastic Surgery · Pearl River, NYNPI 1306068671

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 24.1% of the total. 2025 is the largest year on record at $3,432, more than ten times the $70 reported in 2019.

$10,593in general payments, 2019–2025

Across 146 payments — averaging $72.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Kerecis Limited$1K
  • Smith+Nephew$1K
  • Integra Lifesciences Corporation$897
  • Axogen$731
  • Avita Medical Americas, LLC$618
  • plus $3K from 18 others
$10,400in research payments, 2019–2025

Across 1 payment — averaging $10,400 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Kerecis Limited$10K

What the payments were for

  • Food & beverage$10,593100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)20$2,549
Kerecis Limited17$1,376
Smith+Nephew27$1,007
Integra Lifesciences Corporation9$897
Axogen7$731
Avita Medical Americas, LLC8$618
Sanara Medtech Inc.5$529
Organogenesis Inc.21$506
Polynovo North America LLC5$482
Solventum Corporation5$349
Access Pro Medical, LLC2$222
Johnson & Johnson2$219
Musculoskeletal Transplant Foundation Inc.4$217
Stryker2$204
Alafair Biosciences, Inc.1$148
Biocomposites Inc1$148
Davol Inc.2$115
Pacira Pharmaceuticals Incorporated1$92
Mentor Worldwide LLC2$70
Lifenet Health1$29
Acera Surgical, Inc.1$28
Zimmer Biomet1$21
Urgo Medical North America, LLC1$19
Hydrofera LLC1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,593 in reported general payments places this provider in the 80th percentile of 363 plastic surgery providers in New York.

See all plastic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$55,029
Medicare patients
76
Services billed
390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic surgery in Pearl River

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →